a developer of biopharmaceutical products
Industry Biotechnology
A.I.dvisor tells us that IFRX and OMGA have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IFRX and OMGA's prices will move in lockstep.
Ticker / NAME | Correlation To IFRX | 1D Price Change % | ||
---|---|---|---|---|
IFRX | 100% | +18.71% | ||
OMGA - IFRX | 30% Poorly correlated | -5.61% | ||
PTGX - IFRX | 30% Poorly correlated | -3.82% | ||
BEAM - IFRX | 29% Poorly correlated | -4.33% | ||
AXSM - IFRX | 28% Poorly correlated | -0.47% | ||
VTGN - IFRX | 28% Poorly correlated | -3.19% | ||
More |
Ticker / NAME | Correlation To IFRX | 1D Price Change % |
---|---|---|
IFRX | 100% | +18.71% |
drugs theme (254 stocks) | 23% Poorly correlated | -1.67% |
biopharmaceuticals theme (50 stocks) | 23% Poorly correlated | -2.60% |
europe theme (179 stocks) | 9% Poorly correlated | -0.09% |
biotechnology theme (238 stocks) | 4% Poorly correlated | -1.76% |